Navigation Links
Validation & Compliance Institute, LLC, to Provide Dietary Supplement GMP Training for NSF International
Date:6/24/2009

ANN ARBOR, Mich., June 24 /PRNewswire/ -- Validation and Compliance Institute (VCI), which provides a full range of compliance services for FDA regulated industries, will offer a series of Dietary Supplement Good Manufacturing Practices (GMPs) trainings for DBA Analytical (DBA), a division of NSF International.

The seminar series enables companies to understand the new GMP regulations for dietary supplements, which the US Food and Drug Administration (FDA) published in 2007. These regulations impact all manufacturers of dietary supplements who sell product in the United States.

The next seminar takes place during Supply Side West, November '09 in Las Vegas.

Compliance with the GMPs helps assure the product produced has the identity, strength, composition, quality and purity that it is represented to possess. Being audited to these requirements will help manufacturers continually improve their processes and bolster consumer confidence.

The new regulations were effective in June 2008 for large companies, but companies with less than 500 employees had until June 2009, and companies with fewer than 20 employees have until June 2010 to comply with the regulations.

"This training reinforces DBA's stature as a leading expert on dietary supplements," said Casey Coy, DBA's Project Manager. "We look forward to offering this unique training to those working within the dietary supplement industry."

Validation & Compliance Institute, LLC: Validation and Compliance Institute (VCI) www.vcillc.com, provides a full range of compliance services for FDA regulated industries. From submissions to process validation VCI can do the work for you, or train you to do it yourself. VCI writes INDs, IDEs, NDAs, 510Ks, PMAs, SOPs, and DMFs.

For more information on VCI's latest innovations contact Dr. Norm Howe at howen@vcillc.com or 734 274 4680. For more information on DBA Analytical's service offerings, please contact Casey Coy at CCoy@DBA-global.com or 734-913-5734.

About DBA Analytical: Established in 1986 to provide expert services to the pharmaceutical and biopharmaceutical industries, and then acquired by NSF International, David Begg Analytical has an outstanding international reputation in the field of pharmaceutical quality management, regulatory compliance and, in particular, high-quality training courses (www.dba-global.com).

About NSF International: NSF International, an independent, not-for-profit organization, helps protect you by certifying products and writing standards for food, water and consumer goods (www.nsf.org). Founded in 1944, NSF is committed to protecting public health and safety worldwide.


'/>"/>
SOURCE Validation and Compliance Institute, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. University of Nevada School of Medicine Professor Confirms Accuracy Through Validation Study Using the CSI Health Station Model 6K
2. Sutter Violating State Safety Laws on Assuring Proper Competency Validation of Strike Staff, Say RNs
3. Michael J. Fox Foundation Commits Up to $2 Million for PD Drug Development Under Target Validation 2008
4. UK Physicians Fear New Revalidation Procedures Will Reduce Morale, Decrease Time with Patients and Belittle GP Professionalism, According to New TNS Healthcare Research
5. Pathwork Diagnostics Collaborates With Guys and St Thomas on Tissue of Origin Test Validation in the UK
6. Webinar Alert: Coverity Announces Verification and Validation of Medical Device Software with Static Analysis - A Review of FDA Guidance and Best Practices
7. MDS Analytical Technologies Announces Validation of Two More Kits for High-Throughput Detection of Melamine in Food
8. Domino/Aronberg Prescription Drug Validation Plan Saves Lives, Protects Privacy, Costs Less
9. Pathwork Tissue of Origin Test Validation Study Published in Journal of Clinical Oncology
10. White Paper Explains Package Validation Requirements For Medical Devices & Combinatory Products
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... ... 27, 2016 , ... An educational campaign aimed at everyone ... courtesy of awareness-driven celebrities and thought leaders. It also provides insight to the ... leaders such as Bioness. , As patients feel increasingly concerned about the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... Aimed at ... human interest stories, which come courtesy of leaders in the nursing and health care ... from leading advocates and associations—namely Abilene Christian University. , As the nursing industry ...
(Date:5/26/2016)... ... May 26, 2016 , ... There are many ways to cook a ... (NHDSC) suggests that Americans prefer their dogs straight off the grill. Of the 90 ... their favorite way to cook a hot dog, far outpacing other cooking methods such ...
(Date:5/26/2016)... Atlanta, Georgia (PRWEB) , ... May 26, 2016 ... ... a certificate in intellectual property (IP) to its specialty academic programs. , Answering ... joins the college’s existing certificate programs in health law, and environmental and land ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
Breaking Medicine News(10 mins):
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... FDA 510(k) clearance covers ... for urological and surgical applications Mauna ... Cellvizio®, the multidisciplinary confocal laser endomicroscopy (CLE) platform, ... US with the 12 th 510(k) clearance ... This new FDA clearance covers Confocal Miniprobes indicated ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
Breaking Medicine Technology: